中华男科学
中華男科學
중화남과학
NATIONAL JOURNAL OF ANDROLOGY
2001年
1期
67-70
,共4页
徐福松%时永华%刘承勇%何映%宁克勤%王庆%黄健%孙志兴%池雷
徐福鬆%時永華%劉承勇%何映%寧剋勤%王慶%黃健%孫誌興%池雷
서복송%시영화%류승용%하영%저극근%왕경%황건%손지흥%지뢰
精泰来%男性免疫性不育%疗效%安全性
精泰來%男性免疫性不育%療效%安全性
정태래%남성면역성불육%료효%안전성
目的：评估精泰来治疗男性免疫性不育的有效性和安全性。 方法：198例病人随机进入精泰来组和强的松组，进行6个月治疗和6个月随访共12个月的随机平行对照试验。 结果：抗精子抗体转阴率精泰来组为83.2％，强的松组64.8％；怀孕率分别为48.7％和18.0％。两组比较有明显差异（P＜0.05）。不良反应的发生率精泰来与强的松分别为15.1%和20.4%。 结论：精泰来可有效治疗男性免疫性不育，并有较好的耐受性。
目的：評估精泰來治療男性免疫性不育的有效性和安全性。 方法：198例病人隨機進入精泰來組和彊的鬆組，進行6箇月治療和6箇月隨訪共12箇月的隨機平行對照試驗。 結果：抗精子抗體轉陰率精泰來組為83.2％，彊的鬆組64.8％；懷孕率分彆為48.7％和18.0％。兩組比較有明顯差異（P＜0.05）。不良反應的髮生率精泰來與彊的鬆分彆為15.1%和20.4%。 結論：精泰來可有效治療男性免疫性不育，併有較好的耐受性。
목적：평고정태래치료남성면역성불육적유효성화안전성。 방법：198례병인수궤진입정태래조화강적송조，진행6개월치료화6개월수방공12개월적수궤평행대조시험。 결과：항정자항체전음솔정태래조위83.2％，강적송조64.8％；부잉솔분별위48.7％화18.0％。량조비교유명현차이（P＜0.05）。불량반응적발생솔정태래여강적송분별위15.1%화20.4%。 결론：정태래가유효치료남성면역성불육，병유교호적내수성。
Objectives: To evaluate the efficacy and safety ofJing-tai-lai(JTL) on male immune infertility. Methods: This study was a randomized parallel control trial over 12 months. A total number of 198 men were randomly divided into JTL and prednisone treatment groups.Results: The pregnancy rate of the JTL group and the prednisone group were 48.7% and 18.0% respectively. The rates of antisperm antibody turned negative were 83.2% and 64.8%. The former was significantly higher as compared with the latter (P＜0.05). The adverse reactions were lower for JTL(15.1%) than for prednisone(20.4%). Conclusions: JTL is an effective, well-tolerated Chinese medicine.
